UPDATE: Precigen Inc. (PGEN) PT Raised to $17 at Wells Fargo After First Patient Dosing of AdenoVerse
Tweet Send to a Friend
(Updated - April 8, 2021 7:31 AM EDT)
Wells Fargo raised its price target on Precigen Inc. (NASDAQ: PGEN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo raised its price target on Precigen Inc. (NASDAQ: PGEN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
